Medicine and Dentistry
Acute Promyelocytic Leukemia
100%
Therapeutic Procedure
78%
DNA Topoisomerase (ATP Hydrolysing)
50%
Molecular Pathology
50%
Clinical Management
50%
Disease
50%
Patient
35%
Retinoic Acid Receptor Alpha
35%
Granulocyte
30%
Tretinoin
28%
Gene
21%
Poison
16%
Pathogenesis
14%
Myeloid Differentiation
14%
Repressor Gene
14%
Chimeric Protein
14%
Assay
11%
Chromosome Translocation
11%
High Risk Population
7%
Differentiation
7%
Bleeding
7%
Spontaneous Remission
7%
Anthracycline
7%
Myelodysplastic Syndrome
7%
Ligand
7%
Programmed Cell Death
7%
Toxicity
7%
Therapeutic Agent
7%
Minimal Residual Disease
7%
Molecularly Targeted Therapy
7%
Chemotherapy
7%
Laryngeal Cancer
5%
In Vitro
5%
Double Stranded DNA
5%
Leukemogenesis
5%
Oncoprotein
5%
Breast Cancer
5%
DNA
5%